Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Quidel’s Antigen Tests Detect the Omicron Variant
Quidel’s Antigen Tests Detect the Omicron Variant


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the following statement from

Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics


Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) today announced that they have entered into a definitive agreement in which Quidel

NanoString to Webcast Presentation from the 40th Annual JP Morgan Healthcare Conference: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString to Webcast Presentation from the 40th Annual JP Morgan Healthcare Conference


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a

Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call


Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report financial results for the first quarter of fiscal year 2022, the period ended November 30, 2021, after the close of the

Acadia Healthcare Expands Footprint in Illinois Through Real Estate Purchase and Establishes New Behavioral Healthcare System Named Montrose Behavioral Health Hospital: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Expands Footprint in Illinois Through Real Estate Purchase and Establishes New Behavioral Healthcare System Named Montrose Behavioral Health Hospital


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has completed the acquisition of the real estate for three currently non-operational facilities, including one adult hospital

Acadia Healthcare Forms Joint Venture with Fairview Health Services: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Forms Joint Venture with Fairview Health Services


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Fairview Health Services, one of Minnesota’s leading health systems. Through this partnership

BIOCORP vereinbart neue Partnerschaft mit H&T über InspairTM: https://mms.businesswire.com/media/20191211005828/en/639213/5/Logo_Biocorp.jpg
BIOCORP vereinbart neue Partnerschaft mit H&T über InspairTM


Aufsichtsrechtliche Meldungen:



BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA-PME), ein französisches Unternehmen, das sich auf die Konzeption, Entwicklung und Herstellung innovativer

Gerresheimer AG: Gerresheimer enters into agreement with major American biotech to develop an innovative pump for rare diseases: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
Gerresheimer AG: Gerresheimer enters into agreement with major American biotech to develop an innovative pump for rare diseases
Gerresheimer AG: Gerresheimer enters into agreement with major American biotech to develop an innovative pump for rare diseases
Gerresheimer AG: Gerresheimer schließt Vereinbarung mit bekanntem US-BioTech Unternehmen zur Entwicklung einer innovativen Pumpe ab: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
Gerresheimer AG: Gerresheimer schließt Vereinbarung mit bekanntem US-BioTech Unternehmen zur Entwicklung einer innovativen Pumpe ab
Gerresheimer AG: Gerresheimer schließt Vereinbarung mit bekanntem US-BioTech Unternehmen zur Entwicklung einer innovativen Pumpe ab
BIOCORP Signs New Partnership Around InspairTM With H&T Presspart: https://mms.businesswire.com/media/20191211005828/en/639213/5/Logo_Biocorp.jpg
BIOCORP Signs New Partnership Around InspairTM With H&T Presspart


Regulatory News:



BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA‐PME), a French company specialized in the design, development, and manufacturing of innovative medical devices

Quidel Announces Sponsorship and Community Partnership With the Chicago Blackhawks
Quidel Announces Sponsorship and Community Partnership With the Chicago Blackhawks


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, has executed a multi-year

Humana and The Humana Foundation Offer Support to Those Affected by Tornados: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana and The Humana Foundation Offer Support to Those Affected by Tornados


Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, launched a series of efforts to assist its members, employees and communities in the Midwest and southern part

Acadia Healthcare Forms Joint Venture With SCL Health to Build a New Behavioral Health Facility in Denver Metro Area: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Forms Joint Venture With SCL Health to Build a New Behavioral Health Facility in Denver Metro Area


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with SCL Health, one of Colorado’s premier healthcare systems. The new partnership will build a new

Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences:
Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences


Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual

DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21 http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21
DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21 http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21
Humana Military Earns URAC Accreditations in Case and Disease Management: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Military Earns URAC Accreditations in Case and Disease Management


Humana Military, a wholly owned subsidiary of Humana Inc. (NYSE: HUM), announced today that it has earned a three-year Case Management Accreditation and a Disease Management Accreditation from URAC

AMN Named Among Top Corporate Boards in Diversity, Equity, and Inclusion Awards: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Named Among Top Corporate Boards in Diversity, Equity, and Inclusion Awards


The AMN Healthcare Board of Directors is one of 10 boards nationwide named as best of the best and finalists for the 2021 National Association of Corporate Directors (NACD) Diversity, Equity &amp

LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) Annual Meeting taking place December

Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™: https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Extends its Distributor Agreement in Japan with Northern Science Consulting for Monolix™


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has extended its

Chemed Corporation to Present at the BofA Securities 2021 Virtual Home Care Conference
Chemed Corporation to Present at the BofA Securities 2021 Virtual Home Care Conference


Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2021 Virtual Home Care Conference on Tuesday, December 7, 2021, at 11:00 AM (ET).



The presentation will

Orlando Health Forms Joint Venture With Acadia Healthcare to Expand Behavioral Health Services in the Region: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Orlando Health Forms Joint Venture With Acadia Healthcare to Expand Behavioral Health Services in the Region


Orlando Health and Acadia Healthcare Company announced today that they have formed a joint venture designed to enhance and expand behavioral health services in the region.


This press release

Acadia Healthcare Forms Joint Venture With Orlando Health: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Forms Joint Venture With Orlando Health


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Orlando Health, one of Central Florida’s premier health systems. With Acadia’s partnership

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain Stimulation Conference, taking place

PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth


Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”)